Putting cures on a strip: Startup makes medicines for the third world
An Oxnard-based startup puts medicines and nutritional supplements on easy-to-use, Listerine-like strips that dissolve in the mouth.
Amgen braces for biosimilars rules
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Brave new biotech: Camarillo startup launches first products
PBS Biotech, a Camarillo-based startup, is bringing its first products to market.
Amgen drug shows blockbuster promise
Putting test results behind the talk at its recent product pipeline review, Thousand Oaks-based Amgen on May 17 released promising results for the Xgeva variant of its potential blockbuster bone drug denosumab.
Beyond biologics: Amgen bets new drugs will pay dividend
Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.
Amgen gets sought-after FDA approval
The Food and Drug Administration has approved the use of Amgen’s bone drug denosumab in patients with certain types of cancer, Amgen announced Nov. 18.
Amgen reports earnings drop
Thousand Oaks-based Amgen said Oct. 25 that third-quarter earnings fell 14 percent to $1.3 billion as revenue flatlined. Amgen is the world’s biggest biotech company and the largest private employer in the Tri-Counties. It reported adjusted earnings per share of $1.36, a decrease of 9 percent compared to the same quarter last year. Total revenue Read More →
